Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |